Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen
Étienne de Montmollin(Université Paris Cité), Romain Sonneville(Université Claude Bernard Lyon 1), E. Papy(Université Claude Bernard Lyon 1), Florence Tubach(Assistance Publique – Hôpitaux de Paris), Nathalie Gault(Inserm), Sarah Chemam(Délégation Paris 7), Bruno Mourvillier(Université Claude Bernard Lyon 1), Michel Wolff(Université Paris Cité), Lila Bouadma(Université Claude Bernard Lyon 1), Laurent Massias(Université Claude Bernard Lyon 1), Éric Mariotte(Hôpital Saint-Louis)
Cited by 112
Related Papers
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis
|Clinical Microbiology and Infection|2016|899
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections
|Cochrane Database of Systematic Reviews|2017|648
Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry
|Arthritis & Rheumatism|2009|631
Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis
|The Lancet Infectious Diseases|2017|473
Understanding brain dysfunction in sepsis
|Annals of Intensive Care|2013|358